Table 2: Summary of proteins associated with at least one approved drug and identified by SDREM from both time-series bulk and single-cell SARS-CoV-2.
For each human protein, we show SDREM-based minimum rank between the bulk and single-cell lists, whether or not it is a known SARS-CoV-2 and a pair of associated approved drug names derived from ChEMBL25, IUPHAR/BPS Guide to Pharmacology, Pharos, or ZINC.
| Gene name | SDREM minRank | SARS-CoV-2 interactor? | Approved drug names |
|---|---|---|---|
| RELA | 11 | N | bortezomib |
| NFKB2 | 26 | N | bortezomib |
| DNMT1 | 31 | Y | azacitidine; decitabine |
| BRD4 | 32 | Y | alprazolam ; fedratinib |
| ERBB2 | 45 | Y | afatinib; neratinib |